| abstract |
The present invention relates to methods of treating hepatitis C infection, HIV infection, AIDS, or AIDS-related complex, or inhibiting HIV replication by administering a compound of Formula I n n n n n n n n n n n n wherein: n X is H or OH; n Y is H or OH; n R 1 is H or halogen (F, Cl, Br, I); n R 2 is H or halogen (F, Cl, Br, I); n R 3 is H, C 1-6 alkyl, C 1-6 fluoroalkyl, or benzyl; n R 4 is H, C 1-6 alkyl, or benzyl; and n R 5 is H or C 1-6 alkyl; n n n n n or pharmaceutically acceptable salts thereof, to a mammal. |